In patients surviving an ACS event, concomitant diabetes mellitus does not influence lipid lowering treatment - results from the dyslipidemia international study (DYSIS) II ACS
Heterozygous familial hypercholesterolaemia: a common entity with unfavorable long-term prognosis in patients with very early ST-segment elevation myocardial infarction